| My Account | Subscribe | Contact Us | Donate |
Home
The International Diabetes Federation (IDF) has called for urgent assessment and responses from regulatory authorities into a possible link between the use of insulin glargine (an insulin analog) and increased risk of cancer. The proposed link is based on findings published on June 26, 2009, in Diabetelogia, the journal of the European Association for the Study of Diabetes (EASD). Read More...
0 comments -
Jul 6, 2009 -
Are you new to the diabetes world? Need to fill in the gaps in your diabetes knowledge? Click here to learn more.
-
Diabetes and Adoption
Rachel and her husband chose to adopt a baby instead of meeting the challenges of handling a high risk pregnancy and Rachel’s type 1 diabetes at the same time. She shares their thought process and ultimate happy ending about the decision to bring a child into their lives.
-
Chris Matthews Makes Time for Diabetes
Hosting Hardball on MSNBC and The Chris Matthews Show keep Chris Matthews working long hours. But Matthews got a lesson in priorities and made some life changes when he was diagnosed with type 2.
-
A Chihuahua with Diabetes
Olivia and her dog both have diabetes and today they comfort and encourage each other through the rigors of dealing with the disease. Plus, find out what it means when your domestic pet is diagnosed with diabetes.
-
Smoking and Diabetes
Smoking has severe effects on your diabetes and your health. Learn why diabetes and smoking are an especially bad combination and get some tips from the experts on how to quit.
-
Continuous Glucose Monitors
CGM is a relatively new technology, but the information it provides is invaluable. Find out what CGM offers and whether it could help you.
The must-have resource for physicians, educators and medical professionals who focus on the treatment of diabetes.
Finally! A fresh take on the “professional” journal. Each bi-monthly issue cuts through the jargon and presents the most important information you need to enhance your practice and assist your patients.
Each bi-monthly issue of Diabetes Health Professional is a self-contained handbook covering products, educational resources and the latest diabetes research, complimented by balanced editorial focused on medical news, drug prescription information, clinical practice recommendations and changing treatment options.
Each quarter we send you the latest, most updated research guides, product guides and educational resource guides available for you and your patients.
Each week the Diabetes Health E-Newsletter delivers links to the very latest in news, reviews, blogs and videos from Diabetes Health direct to your inbox.
As a subscriber you'll get access to the amazing Diabetes Health Digital Advantage™ so you can read the current issue of Diabetes Health magazine online wherever you are!
Top Diabetes News and Blogs
Dear Aisha and David, Read more...
A 24-week study of the effects of red yeast rice on the cholesterol levels of people who cannot take statins shows that the ancient Asian food could be a viable statin alternative. Read more...
Women who frequently snore-at least three nights a week-run a substantially higher risk of developing gestational diabetes during pregnancy than non-snorers. Read more...
Of all the quests that researchers have undertaken in search of a cure or decisive treatment for type 1 diabetes, the search for a vaccine has to be the boldest. But how would you develop such a vaccine, and how would it work? Read more...
I would exercise if I had more time... if I had a health club membership... if it didn't hurt so much... if I knew what exercises to do... if I could do it with my family... if I could control my blood sugar...
Read more...
Roche Diabetes Care Announces Unique Coaching Program for Diabetes Educators as Part of Long-Term Commitment to Fight the Disease
Read more...
The National Diabetes Education Program (NDEP) is working hard to change people's attitudes about diabetes. A federally funded program sponsored by the National Institutes of Health (NIH) and the Centers for Disease Control and Prevention (CDC), the NDEP has more than 200 partners at the federal, state, and local levels, all working together to reduce the morbidity and mortality associated with diabetes. Read more...
UK-based GW Pharmaceuticals has entered into a strategic alliance with Professor Mike Cawthorne and the Clore Laboratory, University of Buckingham, to research the use of cannabinoids-chemical compounds derived from marijuana-in the treatment of type 2 diabetes. Read more...
Scientists have identified five genetic biomarkers that predict how well a type 2 patient will respond to the drug Actos. Their work could be the first step toward a system that would allow doctors to predetermine which drugs will best help each person with diabetes. Read more...
